glycine has been researched along with Carcinoma, Hepatocellular in 67 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Boron has an important potential for facilitating biological activity and for use in pharmaceutical drug design." | 5.72 | Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma. ( Berikten, D; Bolat, M; Gündüz, MK; Kaymak, G; Köse, DA, 2022) |
| " The orally bioavailable proteasome inhibitor MLN2238 (ixazomib) has been demonstrated to have anticancer activity." | 5.48 | Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells. ( Augello, G; Azzolina, A; Cassata, G; Cervello, M; Cusimano, A; Di Sano, C; Emma, MR; Modica, M; Montalto, G; Puleio, R, 2018) |
| "Glycine is a simple non-essential amino acid with potential antiangiogenic effects." | 5.40 | Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells. ( Al Saeedi, M; Ambrazevičius, M; Bruns, H; Lin, S; Petrulionis, M; Schemmer, P; Schultze, D; Strupas, K; Yamanaka, K, 2014) |
| "Molybdenum dioxide-gadolinium-arginine/glycine/aspartic acid (MoS₂-Gd-RGD) sequences targeting nano-contrast agents that specifically bind to human hepatocellular carcinoma (HCC) HepG₂ cells were synthesized, and their targeting imaging effects on HCC cells and models were evaluated." | 4.02 | Molybdenum Dioxide (MoS₂)/Gadolinium (Gd) Containing Arginine-Glycine-Aspartic Acid (RGD) Sequences as New Nano-Contrast Agent for Cancer Magnetic Resonance Imaging (MRI). ( Hao, X; Li, W, 2021) |
| "Patients with chronic hepatitis C are expected to receive this treatment worldwide." | 2.52 | Does herbal medicine reduce the risk of hepatocellular carcinoma? ( Rino, Y; Yamamoto, N; Yukawa, N, 2015) |
| "We find high GCS flux in hepatocellular carcinoma (HCC), supporting nucleotide biosynthesis." | 1.72 | Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth. ( Aizenshtein, E; Besser, E; Feldman, A; Fokra, M; Hallo, E; Mukha, D; Nevo-Dinur, K; Sarvin, B; Sarvin, N; Schug, ZT; Shlomi, T, 2022) |
| "Boron has an important potential for facilitating biological activity and for use in pharmaceutical drug design." | 1.72 | Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma. ( Berikten, D; Bolat, M; Gündüz, MK; Kaymak, G; Köse, DA, 2022) |
| "Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease in developed countries." | 1.56 | Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease. ( Caussy, C; Loomba, R; Mills, PJ, 2020) |
| " The orally bioavailable proteasome inhibitor MLN2238 (ixazomib) has been demonstrated to have anticancer activity." | 1.48 | Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells. ( Augello, G; Azzolina, A; Cassata, G; Cervello, M; Cusimano, A; Di Sano, C; Emma, MR; Modica, M; Montalto, G; Puleio, R, 2018) |
| "Glycine is a simple non-essential amino acid with potential antiangiogenic effects." | 1.40 | Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells. ( Al Saeedi, M; Ambrazevičius, M; Bruns, H; Lin, S; Petrulionis, M; Schemmer, P; Schultze, D; Strupas, K; Yamanaka, K, 2014) |
| "Hepatocellular carcinoma is the most common form of primary hepatic carcinoma." | 1.37 | Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model. ( Chan, SH; Chang, Y; Kung, HC; Lin, WJ; Lin, WY; Liu, SW; Luo, TY; Peng, CL; Tang, IC, 2011) |
| "Apoptosis of the cells of liver cancer cell line HepG2 could be induced by TNF alpha and actinomycin D (Act D)." | 1.33 | [Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis]. ( Bi, MR; Chen, LY; Ma, YJ; Wang, Y; Yang, BS, 2005) |
| "Fifty-four patients were diagnosed as hepatocellular carcinoma (n=9), hilar tumours (n=20) and 25 patients with non-parenchymal tumours including colorectal metastasis (n=15) and miscellaneous tumours (n=10)." | 1.32 | Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test. ( Bennink, RJ; Dinant, S; Erdogan, D; Gouma, DJ; Heijnen, BH; Kok, M; Straatsburg, IH; van Gulik, TM, 2004) |
| "In fast-growing hepatomas, the activity could not be detected by either enzymatic or immunological assay." | 1.25 | Alteration of glycine N-methyltransferase activity in fetal, adult, and tumor tissues. ( Heady, JE; Kerr, SJ, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (41.79) | 18.7374 |
| 1990's | 10 (14.93) | 18.2507 |
| 2000's | 12 (17.91) | 29.6817 |
| 2010's | 9 (13.43) | 24.3611 |
| 2020's | 8 (11.94) | 2.80 |
| Authors | Studies |
|---|---|
| Mukha, D | 1 |
| Fokra, M | 1 |
| Feldman, A | 1 |
| Sarvin, B | 1 |
| Sarvin, N | 1 |
| Nevo-Dinur, K | 1 |
| Besser, E | 1 |
| Hallo, E | 1 |
| Aizenshtein, E | 1 |
| Schug, ZT | 1 |
| Shlomi, T | 1 |
| Kusunoki, H | 1 |
| Hamaguchi, I | 1 |
| Kobayashi, N | 1 |
| Nagata, T | 1 |
| Mehtiyev, T | 1 |
| Karaman, EF | 1 |
| Ozden, S | 1 |
| Labeur, TA | 1 |
| Cieslak, KP | 2 |
| Van Gulik, TM | 4 |
| Takkenberg, RB | 1 |
| van der Velden, S | 1 |
| Lam, MGEH | 1 |
| Klümpen, HJ | 2 |
| Bennink, RJ | 4 |
| van Delden, OM | 1 |
| Hamano, M | 1 |
| Tomonaga, S | 1 |
| Osaki, Y | 1 |
| Oda, H | 2 |
| Kato, H | 1 |
| Furuya, S | 1 |
| Hao, X | 1 |
| Li, W | 1 |
| Gündüz, MK | 1 |
| Bolat, M | 1 |
| Kaymak, G | 1 |
| Berikten, D | 1 |
| Köse, DA | 1 |
| Augello, G | 1 |
| Modica, M | 1 |
| Azzolina, A | 1 |
| Puleio, R | 1 |
| Cassata, G | 1 |
| Emma, MR | 1 |
| Di Sano, C | 1 |
| Cusimano, A | 1 |
| Montalto, G | 1 |
| Cervello, M | 1 |
| Rassam, F | 1 |
| Olthof, PB | 1 |
| Takkenberg, BR | 1 |
| Beuers, U | 1 |
| van Lienden, KP | 1 |
| Besselink, MG | 1 |
| Busch, OR | 1 |
| Verheij, J | 2 |
| Mills, PJ | 1 |
| Caussy, C | 1 |
| Loomba, R | 1 |
| Huang, PW | 2 |
| Tsai, SC | 2 |
| Luo, TY | 3 |
| Kao, CH | 2 |
| Lin, WY | 3 |
| Bruns, H | 1 |
| Petrulionis, M | 1 |
| Schultze, D | 1 |
| Al Saeedi, M | 1 |
| Lin, S | 1 |
| Yamanaka, K | 1 |
| Ambrazevičius, M | 1 |
| Strupas, K | 1 |
| Schemmer, P | 1 |
| Rino, Y | 1 |
| Yukawa, N | 1 |
| Yamamoto, N | 1 |
| De Bari, B | 1 |
| Jumeau, R | 1 |
| Deantonio, L | 1 |
| Adib, S | 1 |
| Godin, S | 1 |
| Zeverino, M | 1 |
| Moeckli, R | 1 |
| Bourhis, J | 1 |
| Prior, JO | 1 |
| Ozsahin, M | 1 |
| Baur, O | 1 |
| Malatesta, M | 1 |
| Perdoni, F | 1 |
| Santin, G | 1 |
| Battistelli, S | 1 |
| Muller, S | 1 |
| Biggiogera, M | 1 |
| Mañas, F | 1 |
| Peralta, L | 1 |
| Raviolo, J | 1 |
| García Ovando, H | 1 |
| Weyers, A | 1 |
| Ugnia, L | 1 |
| Gonzalez Cid, M | 1 |
| Larripa, I | 1 |
| Gorla, N | 1 |
| Tang, IC | 2 |
| Liu, SW | 1 |
| Chan, SH | 1 |
| Kung, HC | 1 |
| Peng, CL | 1 |
| Chang, Y | 1 |
| Lin, WJ | 1 |
| Parfrey, H | 1 |
| Mahadeva, R | 1 |
| Ravenhill, NA | 1 |
| Zhou, A | 1 |
| Dafforn, TR | 1 |
| Foreman, RC | 1 |
| Lomas, DA | 1 |
| ROTHERHAM, J | 2 |
| IRVIN, JL | 2 |
| IRVIN, EM | 2 |
| HOLBROOK, DJ | 2 |
| WAGLE, SR | 1 |
| MORRIS, HP | 1 |
| WEBER, G | 1 |
| WU, C | 1 |
| BAUER, JM | 1 |
| TERRANOVA, T | 2 |
| FEO, F | 2 |
| GRAVELA, E | 2 |
| GABRIEL, L | 2 |
| DELOECKER, W | 2 |
| ATCHLEY, WA | 1 |
| BHAGAVAN, NV | 1 |
| MORSE, PA | 1 |
| POTTER, VR | 1 |
| DUNN, WL | 1 |
| Erdogan, D | 1 |
| Heijnen, BH | 1 |
| Kok, M | 1 |
| Dinant, S | 1 |
| Straatsburg, IH | 1 |
| Gouma, DJ | 1 |
| Oxombre, B | 1 |
| Kouach, M | 1 |
| Moerman, E | 1 |
| Formstecher, P | 1 |
| Laine, B | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
| Minchenko, O | 1 |
| Opentanova, I | 1 |
| Minchenko, D | 1 |
| Ogura, T | 1 |
| Esumi, H | 1 |
| Wang, Y | 1 |
| Ma, YJ | 1 |
| Yang, BS | 1 |
| Bi, MR | 1 |
| Chen, LY | 1 |
| Akamoto, S | 1 |
| Okano, K | 1 |
| Sano, T | 1 |
| Yachida, S | 1 |
| Izuishi, K | 1 |
| Usuki, H | 1 |
| Wakabayashi, H | 1 |
| Suzuki, Y | 1 |
| Lee, SJ | 1 |
| Lim, KT | 1 |
| Imai, Y | 1 |
| Nakatsuru, Y | 1 |
| Ishikawa, T | 1 |
| Yuan, TT | 1 |
| Faruqi, A | 1 |
| Shih, JW | 1 |
| Shih, C | 1 |
| Nishizaki, T | 1 |
| Matsumata, T | 1 |
| Taketomi, A | 1 |
| Yamamoto, K | 1 |
| Sugimachi, K | 1 |
| Melkonian, AD | 1 |
| Gaylor, JD | 1 |
| Cousins, RB | 1 |
| Grant, MH | 1 |
| Mack, KD | 1 |
| Walzem, R | 1 |
| Zeldis, JB | 1 |
| Rhee, MS | 1 |
| Galivan, J | 2 |
| Tyobeka, EM | 1 |
| Sherman, ML | 1 |
| Rosowsky, A | 1 |
| Bismut, H | 1 |
| Caron, M | 1 |
| Coudray-Lucas, C | 1 |
| Capeau, J | 1 |
| Burczynski, ME | 1 |
| Harvey, RG | 1 |
| Penning, TM | 1 |
| Oon, CJ | 1 |
| Chen, WN | 1 |
| Zhao, Y | 1 |
| Teng, SW | 1 |
| Leong, AL | 1 |
| Tarao, K | 1 |
| Heady, JE | 2 |
| Kerr, SJ | 3 |
| Mori, M | 1 |
| Tatibana, M | 1 |
| Rhee, M | 1 |
| Priest, DG | 1 |
| Bunni, M | 1 |
| Freisheim, JH | 1 |
| Whiteley, JM | 1 |
| Martin, DW | 2 |
| Owen, NT | 1 |
| Szewczuk, A | 1 |
| Albert, Z | 1 |
| Desai, L | 1 |
| Ogawa, Y | 2 |
| Mauritzen, CM | 1 |
| Taylor, CW | 2 |
| Starbuck, WC | 3 |
| Moskowitz, G | 1 |
| Busch, H | 2 |
| Wilson, RK | 1 |
| Jordan, J | 1 |
| Shimizu, T | 1 |
| Robinson, SH | 1 |
| Rugstad, HE | 1 |
| Yannoni, C | 1 |
| Tashjian, AH | 1 |
| Goriukhina, TA | 1 |
| Lebedeva, SB | 1 |
| Poirier, LA | 1 |
| Pickart, L | 1 |
| Thayer, L | 1 |
| Thaler, MM | 1 |
| Hogan, BL | 1 |
| Murden, S | 1 |
| Mundt, D | 1 |
| Hadjiolov, D | 1 |
| Iwamoto, K | 1 |
5 reviews available for glycine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Top | 2015 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug | 2004 |
[Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C].
Topics: Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combin | 2001 |
Modulation of tRNA methyltransferase activity by competing enzyme systems.
Topics: Animals; Brain; Carcinoma, Hepatocellular; Catechol O-Methyltransferase; Estrogens; Female; Fetus; G | 1974 |
1 trial available for glycine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Digestive System Neoplasms; Digestive System Sur | 2007 |
61 other studies available for glycine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth.
Topics: Carcinoma, Hepatocellular; Folic Acid; Glycine; Glycine Dehydrogenase (Decarboxylating); Humans; Lip | 2022 |
Chemical shift assignments of a fusion protein comprising the C-terminal-deleted hepatitis B virus X protein BH3-like motif peptide and Bcl-x
Topics: Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Hepatocellular; Dipeptides; Glycine; Hepati | 2022 |
Alterations in cell viability, reactive oxygen species production, and modulation of gene expression involved in mitogen-activated protein kinase/extracellular regulating kinase signaling pathway by glyphosate and its commercial formulation in hepatocellu
Topics: Carcinoma, Hepatocellular; Cell Line; Cell Survival; Gene Expression; Glycine; Glyphosate; Herbicide | 2023 |
The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT/CT for selective internal radiation therapy in hepatocellular carcinoma.
Topics: Adult; Aniline Compounds; Carcinoma, Hepatocellular; Female; Glycine; Humans; Liver Neoplasms; Male; | 2020 |
Transcriptional Activation of
Topics: Activating Transcription Factor 4; Animals; Biological Availability; Carcinoma, Hepatocellular; Cell | 2020 |
Molybdenum Dioxide (MoS₂)/Gadolinium (Gd) Containing Arginine-Glycine-Aspartic Acid (RGD) Sequences as New Nano-Contrast Agent for Cancer Magnetic Resonance Imaging (MRI).
Topics: Animals; Arginine; Aspartic Acid; Carcinoma, Hepatocellular; Contrast Media; Gadolinium; Glycine; Li | 2021 |
Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma.
Topics: Antioxidants; Boron; Boron Compounds; Carcinoma, Hepatocellular; Glycine; Humans; Liver Neoplasms | 2022 |
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Boron Compounds; Carcinoma, Hepatocellular; Glycine; Humans; Liver N | 2018 |
Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma.
Topics: Aged; Aniline Compounds; Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Female; Glycine; | 2019 |
Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease.
Topics: Carcinoma, Hepatocellular; Disease Progression; Glycine; Glyphosate; Humans; Liver; Liver Cirrhosis; | 2020 |
Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Ethiodized Oil; Glycine; Liver Neoplasms | 2013 |
Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells.
Topics: Angiogenesis Inhibitors; Carcinoma, Hepatocellular; Cell Line, Tumor; Glycine; Humans; Liver Neoplas | 2014 |
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
Topics: Aged, 80 and over; Aniline Compounds; Carcinoma, Hepatocellular; Glycine; Humans; Imino Acids; Liver | 2016 |
Liver function declines with increased age.
Topics: Adolescent; Adult; Age Factors; Aged; Aging; Aniline Compounds; Body Surface Area; Carcinoma, Hepato | 2016 |
Hepatoma tissue culture (HTC) cells as a model for investigating the effects of low concentrations of herbicide on cell structure and function.
Topics: Animals; Carcinoma, Hepatocellular; Cell Death; Dose-Response Relationship, Drug; Flow Cytometry; Fl | 2008 |
Genotoxicity of AMPA, the environmental metabolite of glyphosate, assessed by the Comet assay and cytogenetic tests.
Topics: Adolescent; Adult; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chromosome A | 2009 |
Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Coordination Complexes; Disease Models, Animal | 2011 |
A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study.
Topics: Animals; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Ethiodized Oil; Glyci | 2013 |
Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease.
Topics: alpha 1-Antitrypsin; Animals; Binding Sites; Carcinoma, Hepatocellular; Chymotrypsin; Crystallograph | 2003 |
Incorporation of glycine into protein fractions of nuclei of liver and hepatoma.
Topics: Carcinoma, Hepatocellular; Cell Nucleus; Glycine; Herbicides; Liver; Liver Neoplasms; Proteins | 1957 |
Incorporation of glycine into protien and nucleic acid fractions of nuclei of liver and hepatoma.
Topics: Carcinoma, Hepatocellular; Cell Nucleus; Glycine; Liver; Liver Neoplasms; Nucleic Acids; Proteins | 1960 |
COMPARATIVE BIOCHEMISTRY OF HEPATOMAS. V. STUDIES ON AMINO ACID INCORPORATION IN LIVER TUMORS OF DIFFERENT GROWTH RATES.
Topics: Alanine; Amino Acids; Aspartic Acid; Carcinoma, Hepatocellular; Glycine; Histocytochemistry; Isoleuc | 1963 |
PEPITASE ACTIVITIES IN TISSUES OF TUMOR-BEARING RATS.
Topics: Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Erythrocytes; Glycine; Leucine; Liver; Li | 1963 |
[ACTION OF METABOLIC INHIBITORS ON ENERGY METABOLISM AND ON PROTEIN SYNTHESIS OF TUMOR AND EMBRYONAL CELLS].
Topics: Adenosine Triphosphate; Amino Acids; Antimetabolites; Carcinoma, Hepatocellular; Cell Biology; Chick | 1963 |
[THE EFFECT OF 2-DESOXYGLUCOSE ON ENERGY METABOLISM AND PROTEIN SYNTHESIS OF TUMOR CELLS AND NORMAL CELLS].
Topics: Animals; Antimetabolites; Bone Marrow; Carcinoma, Hepatocellular; Chick Embryo; Embryo, Mammalian; E | 1964 |
THE EFFECTS OF CORTISOL ON THE INCORPORATION OF GLYCINE CARBON INTO THE NUCLEIC ACIDS OF NORMAL AND MALIGNANT TISSUES.
Topics: Carbon; Carbon Isotopes; Carcinoma, Hepatocellular; DNA; DNA, Neoplasm; Glycine; Hydrocortisone; Liv | 1964 |
SALINE-SOLUBLE PREPARATIONS OF DEOXYRIBONUCLEOPROTEINS.
Topics: Acetates; Alanine; Aminobutyrates; Aminocaproates; Aminocaproic Acid; Animals; Cadmium; Caprylates; | 1964 |
THE IN VIVO EFFECTS OF CORTISOL ON PROTEIN METABOLISM IN NORMAL AND MALIGNANT TISSUES.
Topics: Carcinoma, Hepatocellular; Glycine; Hydrocortisone; Liver; Liver Neoplasms; Neoplasm Proteins; Neopl | 1964 |
PYRIMIDINE METABOLISM IN TISSUE CULTURE CELLS DERIVED FROM RAT HEPATOMAS. I. SUSPENSION CELL CULTURES DERIVED FROM THE NOVIKOFF HEPATOMA.
Topics: Animals; Carcinoma, Hepatocellular; Cell Culture Techniques; Floxuridine; Fluorouracil; Glycine; Liv | 1965 |
ETHIONINE CARCINOGENESIS IN THE RAT.
Topics: Carbon Isotopes; Carcinogenesis; Carcinogens; Carcinoma, Hepatocellular; DNA; DNA, Neoplasm; Ethioni | 1965 |
Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.
Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Bile Duct Neoplasms; Carcinoma, Hepatocellular; F | 2004 |
The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain.
Topics: Age of Onset; Amino Acid Substitution; Binding Sites; Carcinoma, Hepatocellular; Cell Line, Tumor; C | 2004 |
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cobalt; Deferoxamine; Enzyme Induction; E | 2004 |
[Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis].
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cysteine; Drug Combinations; Glycine; Glycyr | 2005 |
Cell death signal by glycine- and proline-rich plant glycoprotein is transferred from cytochrome c and nuclear factor kappa B to caspase 3 in Hep3B cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; DNA; En | 2008 |
A polymorphism at codon 160 of human O6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Base Sequence; Carcinoma, Hepatocellular; Chil | 1995 |
The mechanism of natural occurrence of two closely linked HBV precore predominant mutations.
Topics: Amino Acid Sequence; Aspartic Acid; Base Sequence; Calorimetry; Carcinoma, Hepatocellular; Cell Line | 1995 |
Levels of amino acids in human hepatocellular carcinoma and adjacent liver tissue.
Topics: Aged; Amino Acids; Carcinoma, Hepatocellular; Cystine; Glycine; Humans; Liver; Liver Neoplasms; Meth | 1995 |
Culture of a differentiated liver cell line, Hep G2, in serum with application to a bioartificial liver: effect of supplementation of serum with amino acids.
Topics: Amino Acids; Artificial Organs; Blood; Carcinoma, Hepatocellular; Cell Differentiation; Cell Divisio | 1994 |
Cationic lipid enhances in vitro receptor-mediated transfection.
Topics: Asialoglycoprotein Receptor; Asialoglycoproteins; Binding, Competitive; Carcinoma, Hepatocellular; C | 1994 |
Effect of a novel antifolate, N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523), on growth of H35 rat hepatoma and HEPG2 human hepatoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cell Line; Deoxyuridine; D | 1993 |
Glucose contribution to nucleic acid base synthesis in proliferating hepatoma cells: a glycine-biosynthesis-mediated pathway.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Cells, Cultured; Cycloserine; Enzyme Inhibitors; | 1995 |
Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione.
Topics: Benzopyrenes; Biotransformation; Carcinoma, Hepatocellular; Catalysis; Dihydroxydihydrobenzopyrenes; | 1998 |
Detection of hepatitis B surface antigen mutants and their integration in human hepatocellular carcinoma.
Topics: Arginine; Blotting, Southern; Carcinoma, Hepatocellular; DNA, Neoplasm; Glycine; Hepatitis B Surface | 1999 |
Alteration of glycine N-methyltransferase activity in fetal, adult, and tumor tissues.
Topics: Animals; Animals, Newborn; Carcinoma, Hepatocellular; Chickens; Female; Gestational Age; Glycine; Im | 1975 |
Glutaminase activity of glutamine-dependent carbamoyl-phosphate synthase from rat ascites hepatoma. Regulation by adenosine triphosphate-magensium and magnesium ion.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Ammonium Chloride; Animals; Bicarbonates; Carbamo | 1977 |
The effect of methotrexate on the folate coenzyme pools in human hepatoma cells in culture.
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Deoxyuridine; Folic Acid; Glycine; Humans; Kinetics | 1991 |
Repression and derepression of purine biosynthesis in mammalian hepatoma cells in culture.
Topics: Acyltransferases; Adenine; Animals; Azacitidine; Carbon Isotopes; Carcinoma, Hepatocellular; Clone C | 1972 |
Activity of some hydrolases in animals with transplanted and spontaneous tumours.
Topics: Aminopeptidases; Animals; Carcinoma, Hepatocellular; Cricetinae; Female; gamma-Glutamyltransferase; | 1973 |
Carboxyl-terminal sequence of the glycine-arginine-rich histone from bovine lymphosarcoma, Novikoff hepatoma and fetal calf thymus.
Topics: Amino Acids; Animals; Arginine; Bromine; Carcinoma, Hepatocellular; Cattle; Chemical Phenomena; Chem | 1969 |
Comparative effects on RNA polymerase of the whole GAR histone and its peptides containing clusters of basic amino acids.
Topics: Amino Acids; Animals; Arginine; Carbon Isotopes; Carcinoma, Hepatocellular; Cattle; Cell Nucleolus; | 1969 |
Structure of the glycine-rich, arginine-rich histone of the Novikoff hepatoma.
Topics: Amino Acid Sequence; Arginine; Carcinoma, Hepatocellular; Chymotrypsin; Glycine; Histones; Liver Neo | 1970 |
[Clinical studies on serum leucyl glycyl glycine hydrolyzing enzyme in cancer. I].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cobalt; Edetic Acid; Electrophoresis; Female; Glycine; Hepat | 1971 |
Labeled bilirubin production by a clonal strain of rat hepatoma cells.
Topics: Animals; Bilirubin; Carbon Isotopes; Carcinoma, Hepatocellular; Clone Cells; Fibroblasts; Glycine; I | 1971 |
Competing methyltransferase systems.
Topics: Adenosine; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Nucleus; Cytoplasm; Gl | 1972 |
[Isoenzyme spectrum of serine transoxymethylase in the liver and in hepatomas].
Topics: Agar; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Electrophoresis; Gels; Glycine; Isoenzyme | 1973 |
Folate deficiency in rats bearing the Walker tumor 256 and the Novikoff hepatoma.
Topics: Adenine; Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Choline; Diet; FIGLU Test; Folic | 1973 |
A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cells, Cultured; DNA; Glycine; Histidi | 1973 |
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. I. Effect of amino acid supply.
Topics: Amino Acids; Animals; Arginine; Asparagine; Carbon Radioisotopes; Carboxy-Lyases; Carcinoma, Hepatoc | 1974 |
Effect of aminoacetonitrile on the metabolism of diethylnitrosamine during liver carcinogenesis.
Topics: Animals; Carbon Dioxide; Carbon Radioisotopes; Carcinoma, Hepatocellular; Esophageal Neoplasms; Glyc | 1974 |
Inhibition of cell growth and of purine biosynthesis by allopurinol and 4-aminopyrazolo(3,4-d)pyrimidine--a comparative study.
Topics: Allopurinol; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cells, Cultured; Clone Cells; | 1974 |